Healthcare -
Biotechnology - NASDAQ - US
$ 57.18
1.35 %
$ 7.27 B
Market Cap
18.93
P/E
HALO - RETAINED EARNINGS
Retained Earnings HALO - Halozyme Therapeutics, Inc.
90.6 M
LAST VALUE
88.07%
2 YEAR CAGR
16.76%
5 YEAR CAGR
8.38%
10 YEAR CAGR